Blueberrypharmaceuticals

Hertab 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Hertab tablets are comes under biological category which is targeted chemotherapy. Hertab tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu & epidermal growth factor receptor activity 3. Targeted therapy 4. Signal transduction prohibitor PRODUCT DETAILS Brand               Hertab Ingredients        Lapatinib Strength           250mg Manufactured   Hetero DOSAGE In HER2 positive advanced breast cancer: The recommended dose of Hertab is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle. Totally 5 tablets of Hertab sho...

Tykerb 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Tykerb tablets are comes under biological category which is targeted chemotherapy. Tykerb tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu & epidermal growth factor receptor activity 3. Targeted therapy 4. Signal transduction prohibitor PRODUCT DETAILS Brand                    Tykerb Ingredients            Lapatinib Strength                250mg Manufactured       GSK DOSAGE In HER2 positive advanced breast cancer: The recommended dose of Tykerb is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day ...

Lapahope 250MG Lapahope 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Lapahope tablets are comes under biological category which is targeted chemotherapy. Lapahope tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu& epidermal growth factor receptor activity 3. Targeted therapy  4. Signal transduction prohibitor MECHANISM OF ACTION Chemically Lapatinib is categorized as 4-anilinoquinazoline derivative, which expels anti-cancer activity by prohibiting intracellular tyrosine kinase domains of EFGR & HER type 2. The ErbB driven tumor cell production has been prohibited by Lapatinib. This growth factor receptor present on cell surface of tumors which may leads to cause cell death. PRODUCT DETAILS Brand                  Lapahope Ingredients          Lapatinib Strength...

HERDUO 250MG Herduo 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Herduo tablets are comes under biological category which is targeted chemotherapy. Herduo tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu& epidermal growth factor receptor activity 3. Targeted therapy  4. Signal transduction prohibitor MECHANISM OF ACTION Chemically Lapatinib is categorized as 4-anilinoquinazoline derivative, which expels anti-cancer activity by prohibiting intracellular tyrosine kinase domains of EFGR & HER type 2. The ErbB driven tumor cell production has been prohibited by Lapatinib. This growth factor receptor present on cell surface of tumors which may leads to cause cell death. PRODUCT DETAILS Brand            Herduo Ingredients     Lapatinib Strength            250mg ...

Lanib 250mg Lanib consist of Lapatinib is primarily indicated for advanced breast cancer. Lanib is used in combination with capecitabine with Lanib tablets are usually indicated for the treatment of metastatic breast cancer patients in whose cancer cells expressed with EGFR 2 (HER2) and patients may already receive an anthracycline, taxane& Transtuzumab. PRODUCT DETAILS: Brand Lanib Ingredients Lapatinib Strength 250mg Manufactured BDR Lanib OVER DOSAGE: The doses of Lanib ranges from 2500mg to 9000mg daily, the duration of therapy should be varied between 1 & 17 days. Symptoms occurred during over dose of Lanib are Sore scalp, sinus tachycardia & mucosal inflammation. Patients should be providing with supportive measures. Hemodialysis is not an effective method for overcoming the over dosage condition of Lanib. SIDE EFFECTS: Diarrhea, Nausea, Vomiting, Stomatitis, Back ...